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Abstract
Accumulating evidence suggests that many tumors have a hierarchical organization, with the bulk of
the tumor composed of relatively differentiated short-lived progenitor cells that are maintained by a
small population of undifferentiated long-lived cancer stem cells. It is unclear, however, whether cancer
stem cells originate from normal stem cells or from dedifferentiated progenitor cells. To address this,
we mathematically modeled the effect of dedifferentiation on carcinogenesis. We considered a hybrid
stochastic-deterministic model of mutation accumulation in both stem cells and progenitors, including
dedifferentiation of progenitor cells to a stem cell-like state. We performed exact computer simulations of
the emergence of tumor subpopulations with two mutations, and we derived semi-analytical estimates for
the waiting time distribution to fixation. Our results suggest that dedifferentiation may play an important
role in carcinogenesis, depending on how stem cell homeostasis is maintained. If the stem cell population
size is held strictly constant (due to all divisions being asymmetric), we found that dedifferentiation acts
like a positive selective force in the stem cell population and thus speeds carcinogenesis. If the stem cell
population size is allowed to vary stochastically with density-dependent reproduction rates (allowing both
symmetric and asymmetric divisions), we found that dedifferentiation beyond a critical threshold leads
to exponential growth of the stem cell population. Thus, dedifferentiation may play a crucial role, the
common modeling assumption of constant stem cell population size may not be adequate, and further
progress in understanding carcinogenesis demands a more detailed mechanistic understanding of stem
cell homeostasis.
Author Summary
Recent evidence suggests that, like many normal tissues, many cancers are maintained by a small popu-
lation of immortal stem cells that divide indefinitely to produce many differentiated cells. Cancer stem
cells may come directly from mutation of normal stem cells, but this route demands high mutation rates,
because there are few normal stem cells. There are, however, many differentiated cells, and mutations
can cause such cells to ”dedifferentiate” into a stem-like state. We used mathematical modeling to study
the effects of dedifferentiation on the time to cancer onset. We found that the effect of dedifferentiation
depends critically on how stem cell numbers are controlled by the body. If homeostasis is very tight (due
to all divisions being asymmetric), then dedifferentiation has little effect, but if homeostatic control is
looser (allowing both symmetric and asymmetric divisions), then dedifferentiation can dramatically has-
ten cancer onset and lead to exponential growth of the cancer stem cell population. Our results suggest
that dedifferentiation may be a very important factor in cancer and that more study of dedifferentiation
and stem cell control is necessary to understand and prevent cancer onset.
Introduction
Most tissues consist of three classes of cells: stem cells, transit-amplifying progenitor cells, and differen-
tiated cells. Multicellular organisms require a tight control of cell division to ensure a proper balance
2between these different cell populations. The cancer stem cell (CSC) hypothesis states that tumors are
also hierarchically organized, with a small sub-population of cancer cells driving cancer growth [1]. In-
dividual cell tracing studies of tumor development strongly support the cancer stem cell hypothesis in
many (but not all) types of cancer [2,3], and identifying these cells in tissues is an ongoing goal in cancer
research. Lineage studies find that malignant tumors contain more cancer stem cells compared to benign
tumors and that cancers gradually lose their tissue-like hierarchical organization as they evolve from the
benign to malignant [2].
Cells escape proliferation control after acquiring a series of mutations in a multi-step process [4].
While some cancers may require only a few mutations [5], the number of required (driver) mutations in
solid cancers is larger, with up to twenty driver mutations [6]. In order to accumulate this critical number
of mutations during a lifetime, cells either have to be long-lived or the mutation rate has to be large [7].
Stem cells have been proposed to be likely candidates for the initial cell of mutation due to their long
lifetime and sustained self-renewal capacity [1]. In addition to their long life span, stem cells are able to
generate full lineages of differentiated cells, thereby perpetuating mutations through clonal expansion.
Given known division and mutation rates, theoretical studies have argued that the necessary number of
mutations for carcinogenesis cannot be obtained in the stem cell population on a reasonable time scale
without assuming either significant selective advantage or elevated mutation rates [4,7]. However, there is
conflicting evidence as to how early in tumor development cancers acquire an elevated mutation rate [8,9]
and several cancer genome sequencing studies have estimated mutation rates during cancer initiation to
be normal for some types of cancer [10–12].
Although a stem cell may sustain the first oncogenic hit, subsequent alterations required for devel-
opment of CSCs can occur in descendent progenitor cells [13]. Dysregulation of pathways involved in
stem cell self-renewal may lead to progenitor cells acquiring a stem cell-like phenotype. It remains an
open question whether cancer stem cells originate from stem cells that escape homeostasis or from dedif-
ferentiated progenitor cells that acquire infinite proliferating potential [14]. There is significant evidence
that dedifferentiation may play a role in establishment of some cancers. In the hematopoietic system, it
has been shown that leukemic stem cells can be generated from committed progenitor cells that acquire
stem cell-like behavior [15]. It has been suggested that acute myeloid leukemia (AML) is a progenitor dis-
ease, where a progenitor acquires abnormal self-renewal potential and“dedifferentiates” to a stem cell-like
state [16,17]. Other myeloid leukemias such as CML (chronic myeloid leukemia) are thought of as stem-
cell diseases [18]. However, although a hematopoietic stem cell is thought to be the cell of origin in the
early phases of CML, in patients with CML blast crisis, granulocyte–macrophage progenitors are thought
to acquire self-renewal capacity through a β-catenin mutation and emerge as the probable CSCs [19].
Using mathematical modeling to investigate the likelihood of mutation occurring in a progenitor versus
a stem cell is a continuing line of investigation [20]. We treat the probability of a mutant progenitor cell
acquiring stem cell-like state as a “dedifferentiation” rate, and we study how this parameter influences
the time to carcinogenesis. We are primarily interested in whether dedifferentiation can speed up the
time to tumor development in hierarchically organized cancers and in what rates of dedifferentiation are
necessary for a noticeable effect.
Prior Related Mathematical Modeling
Certain aspects of the cancer stem cell hypothesis have previously been addressed by mathematical
models. It has been shown that having a hierarchical tissue design, where a small population of stem
cells maintains a transient population of differentiating cells, may slow the accumulation of mutations
and protect against cancer [21–23]. The question of whether genetic instability (resulting in hyperactive
mutation rate) is an early or later event in mutation acquisition leading to cancer has been addressed by
several groups (see [4] for review). Most mathematical models find that the onset of genetic instability
should be an early event, if at least some of the mutations are neutral. However, sequencing suggests
that the mutator phenotype is expressed relatively late in cancer progression [9].
3Stem cell populations are typically small. Hence, the dynamics of mutant cells in the stem cell
population are highly sensitive to stochastic fluctuations. A tumor begins with a single mutated cell, so
there is a substantial chance of mutant extinction due to random events. Genetic drift and stochastic
clonal extinction in stem cell lineages have been experimentally demonstrated for both normal tissue
stem cells [24–26] and cancer stem cells [2] in several tissue types. A deterministic model of mutation
acquisition in stem cells will significantly underestimate the time to cancer establishment [27]. Many
models of mutation acquisition use a stochastic approach and are concerned with calculating time to
emergence or fixation (or when the number of mutant cells reaches some threshold value used in diagnosis)
of a mutant cell with fitness r = 1 + s in a population of size Nsc.
The waiting time for cancer is often defined as the time until a particular number of mutation events
have occurred in at least one cell. Iwasa et al. [28] considered a two stage Moran model and described
conditions under which “stochastic tunneling” can occur. (In this phenomenon, cells with two mutations
reach fixation before cells with one mutation reach fixation.) Durrett et al. [29] obtained asymptotic
estimates of waiting times until a cell with i mutations first appears under assumption of neutrality
(s = 0). These models typically consider a fixed population size [5, 18, 20, 30–34]. The fixed population
assumption is supposed to reflect homeostasis in the stem cell population, though how homeostasis is
achieved is typically not addressed. Although the Moran model captures the stochastic nature of mutation
acquisition, this type of model is not capable of describing mutations that lead to the change of stem
cell division pattern that results in possible expansion of the stem cell pool, which in turn leads to
tumor growth. Some recent models also consider mutation accumulation in exponentially growing cell
populations [35–38]. Beerenwinkel et al. [6] used the Wright-Fisher model with exponentially growing
population size to look at effect of selection on the waiting time to cancer, and they predicted that the
observed genetic diversity of colorectal cancer genomes can arise under a normal mutation rate (taken
to be u = 10−7 per cell division) if the average selective advantage per mutation is on the order of
1%. Similar calculations using a discrete branching process found s = 0.4% given u = 10−5 [35]. Note
that increased mutation rates due to genetic instability would allow even smaller selective advantages
during tumorigenesis, but neutral mutants (s = 0) result in waiting times that are too long compared
with disease incidence. Other groups have also concluded that for normal mutation rates and neutral
mutants, mutations in multiple genes in acquired hematopoietic disorders are most likely very rare events,
as acquisition of multiple mutations typically requires development times that are too long compared to
disease incidence [31].
Spencer et al. [39] and Ashkenazi et al. [40] have focused on the sequential order of mutations associated
with increased rates of proliferation, decreased rate of death, increased mutation rate, and other hallmarks
of cancer that must accumulate before emergence of cancer. The sequence of mutations with the shortest
waiting time to getting all the necessary mutations is considered the most likely mutational pathway
[20, 39]. However, these models do not consider the possibility that dedifferentiation of progenitor cells
can affect the time to multiple mutation acquisition.
The dividing progenitor cell population has previously been described by multi-compartment ODE
models, with cells moving between compartments as they age [40–42]. Note that in these models the
exact number of different stages of differentiation is ambiguous and does not exactly correspond to mitotic
events, as cells may undergo more than one division in each compartment stage [41]. Most of these models
of age-structured cell populations assume a stem cell proliferation rate that is dependent on the total
number of cells and thus incorporate negative feedback as a means of achieving homeostasis [43,44]. These
deterministic models have focused on mechanisms that could regulate cell numbers that are necessary for
homeostasis and efficient repopulation. We use a similar mathematical approach to model the progenitor
population as [44], but we couple it to stochastic dynamics in the stem cell compartment.
Some studies have previously considered the impact of the asymmetry of cell division on stem cell
dynamics [30, 45]. Suppose that upon division a stem cell can produce zero, one, or two stem cells with
probabilities αD, αA, and αS , respectively (Fig. 1A). The mean number of stem cell offspring is given
4by αA + 2αS . In that case, the stem cell population is best described by a branching process with the
expected number of cells at time t given by (αA+2αS)
t. However, a branching process either goes extinct
or undergoes exponential growth, and thus it cannot capture stem cell dynamics at equilibrium. One
solution is to use a conditional branching process [46], where the probabilities for a branching process are
conditioned to the total population size remaining constant by an unspecified sampling mechanism (i.e.,
assuming that the stem cell population remains in homeostasis), and this approach has been applied to
stem cell dynamics [34]. We consider both fixed and time-varying but bounded stem cell population size
in our models.
Our Modeling Approach
We use mathematical modeling to study how the possibility of “dedifferentiation” of mutant progenitor
cells into a stem cell-like state affects the waiting time to carcinogenesis. Dividing progenitor cells have
large growing populations, so we use a deterministic model to describe their evolutionary dynamics.
Discretizing the progenitor cell population based on the number of divisions a cell has completed, we
obtain an age-structured partial-differential-equation model for the number of differentiated cells of age
a at time t. This modeling approach is based on the assumption that maturation of progenitor cells
is a continuous process which progresses with a constant velocity. For stem cell populations, stochastic
effects are important, because the proliferating stem cell population is typically small. We use a stochastic
model for stem cell dynamics as a boundary condition to the PDE governing differentiated cell expansion
(Fig. 1B and C.) There is also feedback from the deterministic progenitor population to the stochastic
stem cell population as a rate of “dedifferentiation”.
To assess the effect of dedifferentiation on time to carcinogenesis, we consider models for stem cell
dynamics with both fixed and variable stem cell numbers (Fig. 1D). We assume neutral fitness of mutant
stem cells, with the proliferation advantage of the mutant phenotype appearing only in the progenitor
stage, in line with what is known for some cancers [47, 48]. The main questions we address are:
1. What is estimated time to carcinogenesis (acquisition of M mutations) in stem cell-driven cancers
if dedifferentiation from the progenitor population is allowed?
2. What magnitude of dedifferentiation rate is needed to significantly shorten time to cancer acquisi-
tion? Will dedifferentiation still change the waiting time to cancer if homeostasis in the stem cell
population is maintained (population size remains constant) or does homeostasis need to be lost?
3. What is the effect of symmetric division of stem cells, which leads to a non-constant stem cell
population size? Do stochastic fluctuations in the size of the stem cell pool speed up time to
malignancy compared to a constant stem cell population size?
Our general compartment model can be applied to different tissues, such as colonic crypts, mammary
cells, and hematopoiesis.
Models
Progenitor Cells
We assume that when progenitor transit-amplifying cells carrying i mutations divide, they produce pro-
gentitor cells of the same maturity stage, obtaining the linear PDE
∂pi
∂t
+
da
dt
∂pi
∂a
= (σ(a)− µ(a))pi. (1)
where pi(a, t) is the progenitor cell density of age a at time t, σ(a) is the age-dependent proliferation rate,
and µ(a) is the age-dependent mortality rate. We assume that the rate of maturation dadt does not depend
5on age a and, without loss of generality, set it equal to 1. Similar age-structured population equations
have been previously studied, with focus on the regulatory feedback mechanisms that are necessary for
homeostasis and structural stability of the steady state solution [42, 44].
Extending Eq. (1) to account for mutations between multiple subpopulations of progenitor cells
(Fig. 1C) we obtain
∂p0
∂t
+
∂p0
∂a
= ((1 − u∗)σ0(a)− µ0(a))p0, (2a)
∂p1
∂t
+
∂p1
∂a
= ((1 − u∗)σ1(a)− µ1(a))p1 + u∗σ0(a)p0, · · · (2b)
∂pk
∂t
+
∂pk
∂a
= (σk(a)− µk(a))pk + u∗σk−1(a)pk−1. (2c)
Here u∗ is the mutation rate per cell per unit time and pi(a, t) is the number of progenitor cells of “age”
a from the subpopulation with i mutations. We assume 0 ≤ i ≤M , and no back mutation is allowed.
We assume that there is a separate stem cell population that give rise to newly born differentiated
cells pi(0, t) that serves as a boundary conditions to the PDE system in Eq. (2). Let ni(t) be the number
of stem cells with i mutations at time t. Let αD,i be the probability of a symmetric division that gives
rise to two differentiated cells, αA,i be the probability of an asymmetric division that gives rise to one
stem cell and one differentiated cell, and αS,i be the probability of a symmetric division that gives rise
to two stem cells. Then
pi(0, t) = (2αD,i + αA,i)ni(t). (3)
If we neglect mutation, the steady state solutions of Eq. (2) have the form
pi(a, t) = αni(t− a)eri(a), (4)
where α = 2αD,i + αA,i is the average number of stem cells of type i produced per division and
ri(a) =
∫ a
0 (σi(s)− µi(s)) ds is the age-dependent growth rate of the differentiated cell population (Sup-
plemental Text). Hence, the long-term age distribution is largely determined by the functional forms of
the differentiated cell birth and death rates (Supplemental Fig. S1 and S2.) Altered birth and death rates
due to mutations can result in mutant subpopulations growing to higher plateaus in size, but the final
population size will be bounded. Our PDE system can be easily modified to have a maximal carrying
capacity Ki for each sub-population. This does not qualitatively change the age distribution of progenitor
cells (Supplemental Fig. S1) and does not significantly affect the fraction of i-mutation cells in the total
progenitor population (Supplemental Fig. S3), so we do not consider it further.
To mimic a maturity switch for cellular proliferation and death, we took the proliferation and death
rates of differentiated cells per unit time to be
σ(a) =
b
2
(1− tanh(ρb(a− ωb))) , and (5a)
µ(a) =
d
2
(1 + tanh(ρd(a− ωd))). (5b)
Here b and d are the maximal proliferation and death/removal rates of progenitor cells. The age at which
the proliferation switch occurs (i.e., half the progenitor cells stop dividing) is given by ωb, and the steepness
of the proliferation switch is determined by ρb. Similarly, the age at which half the cells begin to undergo
apoptosis is given by ωb, and the steepness of the death switch is controlled by ρd. If ωb < ωd, then
differentiated cells between the ages of ωb and ωd are not replicating (senescent). Note that setting either
of these values to zero results in a uniform rate of birth/death. Effects of varying proliferation/death
parameters are shown in Supplemental Fig. S2. The parameters governing proliferation, in particular
b and ωb, have much larger influence on the final differentiated cell population size than parameters
governing death/removal. The steepness of the switch does not change the age distribution..
6Stem Cells
Constant Stem Cell Population Size
To model the evolutionary dynamics of a stem cell population under strict homeostasis (resulting in a
fixed stem cell population size), we used the Moran stochastic process for M + 1 different types, with
mutations between types and neutral fitness [46]. Let the number of individuals carrying each possible
number of mutations be given by n = (n0, n1, ..., nM ), where
∑M
i=0 ni = Nsc. We considered two versions
of this model, with and without dedifferentiation. In both cases, we assumed that each stem cell divides,
on average, every Tgen chronological time units. Thus, in a population of size Nsc, the average time
between divisions was Tgen/Nsc.
In the first model, no dedifferentiation of progenitor cells was possible. Every Tgen/Nsc time units, a
single randomly chosen stem cell j was removed and one cell i was born with probability given by
P (n→ n+ ei − ej) =
nj
Nsc
[
M∑
h=0
mi,h
nh
Nsc
]
, (6)
where mi,h is the probability of changing to type i from type h per replication event, and ej is a unit
vector with 1 in the jth column. We considered a linear cascade of mutations in which the mutation
matrix [mi,h] is given by 

1− u1 0 0 · · · 0
u1 1− u2 0 · · · 0
0 u2 0 · · · 0
...
...
...
. . .
...
0 0 0 · · · 1

 . (7)
We also considered a version of the model in which dedifferentiation of two-mutation differentiated
cells was allowed, but the total stem cell population size remained fixed. In this model, the probability
of death of a j-mutation stem cell and birth of an i-mutation cell was given by
P (n→ n+ ei − ej) = (1− εf)
nj
Nsc
[
M∑
h=0
mi,h
nh
Nsc
]
+ δi,2ε
∫
a
p2(a) da∑
i
∫
a pi(a) da
, (8)
where ε is the proportion of cells in the stem cell pool that come from dedifferentiated cells at each repli-
cation event, and δi,2 is the Kronecker delta function signifying that that only two-mutation progenitor
cells can dedifferentiate. Here
f =
∫
a p2(a) da∑
i
∫
a
pi(a) da
is the proportion of two-mutation cells of all ages in the progenitor population, given that pi(a) is the
density of differentiated cells of age a carrying i mutations. We also considered a version of the model
in which all progenitor cells, regardless of the number of mutations, could dedifferentiate (Supplemental
Material).
Because the Moran model has been studied extensively, we were able to use several existing results on
the time to emergence and fixation of mutants. Let τM be the first time at which an individual carrying
M mutations emerges who will go on to fix in the population. We focus on the case M = 2 because
sequencing of acute myeloid leukemia genomes suggests that there are 2 driver mutations present [49].
(See discussion for more details.) Using branching process approximations, Durrett et al. [29] calculated
the waiting time for the Moran model under neutral drift of prior mutants. For M = 2, the probability
density function for τ2 is given by
φ(Nscu1
√
u2ρfixτ2 = t) ≈
1− e−2t/λ
1 + e−2t/λ
exp
(
−
∫ t
0
1− e−2ξ/λ
1 + e−2ξ/λ
dξ
)
, (9)
7where λ = Nscu1, and ρfix is the probability that a single mutant individual will fix in a population of
size Nsc. For neutral drift, ρfix = 1/Nsc, and for weak selection
ρfix =
1− exp(−2s)
1− exp(−2sNsc)
, (10)
where M -mutation cells have advantage s≪ 1 [46].
The time to fixation of the subpopulation with M = 2 mutations is a sum of two random variables:
the time τ2 until appearance of a successful two-mutation cell (Eq. (9)) and the waiting time τfix from
the time that mutant first appears until that mutant fixes [50]. Note that this time is given in units of
stem cell generation times Tgen. The pdf of the total fixation time, Tfix, is given by the convolution
φ(Tfix) =
∫ Tfix
0
φ(t)φ˜(Tfix − t) dt (11)
of the probability density functions φ for time to first appearance of successful mutant and φ˜ for
time it takes that mutant to fix. φ˜ can be obtained from the backward Kolmogorov equation for the
probability of fixation f of a gene with initial frequency p0 before time t:
∂f(p0, t)
∂t
=
p0(1− p0)
2Nsc
∂2f(p0, t)
∂p02
+ sp0(1− p0)
∂f(p0, t)
∂p0
, (12)
subject to boundary conditions f(1, t) = 1 and f(0, t) = 0 and initial condition f(p0, 0) = δ(p0). Di-
viding f by the ultimate probability of fixation ρfix and differentiating with respect to t, we obtain the
probability density function for φ˜ as a function of initial allele frequency p0 [51].
Variable Stem Cell Population Population Size
Our previous stem cell models couple birth and death events to keep the population size fixed, but we
next decoupled these events to allow for a stochastically varying population size. For clarity, we refer to
the total stem cell population size in this model by S(t). Again assuming that the average replication
time of a stem cell is Tgen, the interval between birth/death events in this stochastic stem cell model
corresponds to Tgen/S(t) time units in the progenitor cell model. We assume that homeostasis in the
stem cell pool is maintained by control of cell fate upon division, and that each stem cell can produce
zero, one, or two stem cell offspring. For example, the possible offspring from a zero-mutation stem cell
are: two differentiated zero-mutation cells with probability αD, one zero-mutation differentiated cell and
one zero-mutation stem cell with probability αA(1 − u), one zero-mutation differentiated cell and one
one-mutation stem cell with probability αAu, two zero-mutation stem cells with probability αS(1− 2u),
and a one zero-mutation stem cell and one one-mutation stem cell with probability 2uαS. (For simplicity
we assume the probability of both offspring carrying new mutations to be negligible.) In general, a stem
cell carrying i mutations can produce k stem cell offspring carrying j mutations with probability P ji (k)
given by
P ii (0) = αD, P
i
i (1) = αA(1− u) + αSu, P i+1i (1) = αAu+ αSu, P ii (2) = αS(1− 2u). (13)
With constant division probabilities αD, αS and αA, this model is a rescaled Galton-Watson branching
process, and the stem cell population either goes extinct in finite time or undergoes exponential growth
when the mean number of stem cell progeny per cell, m = 2αS+αA, is greater than one [52]. To describe
a stem cell population under homeostasis, the probabilities αD, αA, and αS must depend on the total
stem cell population size S(t). We model a carrying capacity Ki for stem cells carrying i mutations, such
that
αA,i = η, αS,i = (1− η)
Kξi
Kξi + S(t)
ξ
, αD,i = (1− η)
S(t)ξ
Kξi + S(t)
ξ
. (14)
8As η approaches one, αA approaches one, so that most of the divisions that occur do not change the stem
cell population size, and we recover the Moran process for all carrying capacity values. The parameter
ξ controls strength of fluctuations about the carrying capacities; as ξ increases, the fluctuations become
smaller. In this model, newly emerging mutants can still go extinct due to stochasticity, but the total
population reaches a quasi-stationary regime at population size Ki. Note that, because this is a quasi-
stationary regime, eventually the stem cell population will go extinct, but the expected time to extinction
is exponentially proportional to Ki for ξ = 1 and η = 0 [53]. We chose the carrying capacity to be large
enough that extinction of the stem cell population does not occur on a physiological timescale, and we
initialized the stem cell population to be at carrying capacity with zero-mutation cells.
We considered two versions of the variable stem cell population size model. In the first case, no
dedifferentiation was possible. In the second case, differentiated cells with K mutations were allowed to
dedifferentiate and re-enter the stem cell population. Let δ be the dedifferentiation rate per two-mutation
progenitor cell per unit time. Then the mean number of cells dedifferentiating in the interval Tgen/S(t)
between two stem cell replications is
λ = δ
Tgen
S(t)
P (t) = δ
Tgen
S(t)
∫
p2(a, t) da. (15)
To introduce dedifferentiated cells into the stem cell population, at each replication event we calculate
the mean number of dedifferentiated progenitor cells λ and update the stem cell population:
[n0, n1, n2]→ [n0, n1, n2 + Poisson(λ)], (16)
After the total stem cell number is updated, the probabilities of reproduction are re-calculated using
Eq. (13), and reproduction is carried out.
Model Parameters
Parameters used are summarized in Table 1. We used parameter estimates from the human hematopoietic
system because parameters for other cancers are less well known. We used M = 2 as the number of
necessary mutations to develop a cancerous phenotype. Although it has been estimated that for the
human hematopoietic system there are 11,000-22,000 stem cells [54], which give rise to all blood and
immune system cells, most of these cells are quiescent and only divide when body sustains an injury and
needs to repopulate the hematopoietic system. Our model only considers actively dividing stem cells,
which have been estimated by various methods to number around 100 [27,55]. The entire actively dividing
stem cell population has previously been modeled as turning over once per year [27], but most recent
estimates have an individual stem cell dividing every 25-50 weeks [56]. However, this is likely an over-
estimate, as it is difficult to distinguish between actively dividing and quiescent stem cell populations.
We assume that an active stem cell divides every 20 weeks, which when multiplied by Nsc results in
active stem cell population turnover time of Tgen = 5 weeks. (The entire stem cell population including
quiescent cells turns over on a much longer timescale.)
Whereas the size of the active hematopoietic stem cell pool is small, the number of progenitor cells
such as granulocyte, erythroid, monocyte, and megakaryocyte colony-forming units (CFU–GEMM) and
granulocyte and monocyte colony-forming units (CFU–GM) is much larger. There are approximately
105 CFU–GEMM cells and 108 CFU–GM cells [57]. There are estimates that each CFU–GEMM may
contribute to hematopoiesis for an average of 60 days (range of 40–340 days) and that it replicates at
an average rate of once every 50 days (range of 35–285 days) [57]. We track the progenitor populations
for L = 20 weeks, and assume that their proliferative potential rapidly drops off after 10 weeks. The
maximal proliferation and death rates, bi and di were chosen so that 100 stem cells results in 10
5 − 106
progenitor cells of all ages.
Not much is known about the selective advantage s provided by driver mutations for different cancer
types, except that it is small (r = 1 + s ≈ 1). Unless stated otherwise, we assume neutral fitness in
9the stem cell pool (s = 0) in our stochastic models throughout the paper, to focus on the effect of
dedifferentiation. We use a range of s = 0 · · · 0.4 for the progenitor cells in the deterministic model.
Mutation estimates per cell division per gene range from about 10−7 in normal cells to 10−2 in case
of chromosomal instability [58]. (Note that the rate of epigenetic change has been estimated to be orders
of magnitude higher than that of genetic change and could also play a role in cancer initiation [10].) A
common value used in many mathematical models is a driver mutation rate of u = 10−5 per division,
obtained by assuming a somatic mutation rate of 10−7 per gene, and about 100 genes that could be
mutated to give same phenotype [35,40]. In normal hematopoietic cells mutation rate has been measured
as u = 10−6 per division [59].
Note that in the stochastic model, which considers every cell division, the mutation rate u can be used
as is, but using chronological time (i.e., weeks or months) means that this value should be multiplied by
the average number of divisions per unit time to obtain u∗. (Mutations that speed up the cell cycle will
then speed up the apparent mutation rate per unit of chronological time in our progenitor model.) The
expected number of doublings from ni stem to pi progenitor cells is log2 (pi/ni) + 2 [41], and the total
number of progenitors cells of type i is pi ≈ αnie
∫
r(a), da. Using values from Table 1, this results in 8−10
cell divisions that take place over 10 weeks, so u∗ ≈ u in equations (2).
Results
The coupled system of stem cells and progenitor cells undergoing mutation and dedifferentiation we mod-
eled is complex. To disentangle the effects of different phenomena, we systematically built up the model.
We first considered the progenitor population alone. We then considered the stem cell population alone,
in models with strict and variable stem cell homeostasis. Finally, we coupled the stem and progenitor
populations through dedifferentiation.
Progenitor Population Alone
We first considered whether mutation and reproduction in the progenitor population could by itself
generate a sustained population of two-mutation cancerous cells. We thus modeled a scenario in which
no stem cell mutations occur, so the boundary condition to the progenitor population system in equations
(2) is simply (Nsc, 0, · · · , 0). Because selection in the progenitor population might favor mutants, we also
assumed that progenitor cells with i mutations have a proliferation rate bi = (1 + s)
ib0 (Eq. 5). This
yields a steady-state age distribution of normal and mutant progenitor cells (Supplemental Fig. 2).
Fig. 2 summarizes results for typical parameter values, showing that for M = 2 mutant cells to be an
appreciable fraction of the population, the mutation rate u and proliferative advantage s must both be
unreasonably high. This is true both if the total progenitor population can grow without bound (Fig. 2a)
and if its growth is restricted (Fig. 2b). Similar findings are obtained if competition between progenitor
subpopulations is included in the model (Supplemental Fig. 3). Consistent with previous work [21,22,31],
these results show stem cell dynamics cannot be ignored in considering time to carcinogenesis, so we next
considered stochastic models of the stem cell population.
Stem Cell Population Alone
We next considered models of the stem cell population. We began without dedifferentiation, so the
dynamics are entirely governed by the stem cells. In modeling cancer, the time to carcinogenesis can be
defined as the time for a single M -mutation cell to emerge, the time for M -mutation cells to pass some
threshold number or fraction, or the time for M -mutation cells to fix in the population. If the mutation
rate is low (such that Nscu≪ 1), then all three definitions are similar, because the time to emergence of
a successful M -mutation cell is long compared to the time from emergence to fixation. However, there
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is large uncertainty regarding effective mutation rates in carcinogenesis (Table 1), so the assumption of
low mutation rate may not always be valid, and we thus calculated times to fixation.
We began our stem cell modeling by considering fixed population size, corresponding to strict home-
ostasis. In this constant Nsc case, we could leverage several analytic results, with which our simulations
agreed well. Fig. 3A shows a typical simulation. The full probability density distribution of time to fixa-
tion is given by Eq. (11) and agrees well with our simulations for high mutation rates (Fig. 3B). The time
to emergence of a successful mutant is of order 1/(
√
Nscu
3/2) stem-cell generations (Eq. (9)). For normal
mutation rates of u = 10−6 − 10−8 per cell division, the mean time until emergence of a two-mutation
cell is 108 − 1011 stem cell generations, which is very long even with a short stem cell generation time.
Because homeostasis is likely imperfect, we also considered a stochastically fluctuating stem cell
population size. We found that, without dedifferentiation, the distributions of times until fixation are very
similar for models with and without fluctuations in the stem cell population size, as long as we condition
on non-extinction of the stem cell population (Fig. 3B). This is true for a wide range of probabilities of
asymmetric division η and strengths of mean reversion ξ (Eq. 14). This agrees with previous findings
that demographic stochasticity does not alter fixation times of neutral mutants in a large population [60],
provided that the carrying capacities of the mutants are the same.
Our results suggest that dynamics within either the progenitor or stem cell compartments considered
separately do not result in carcinogenesis in the hematopoietic system on a realistic time-scale, provided
that cancer-causing mutations occur at normal mutation rates, selection advantages relative to wild-type
stem cells do not appear until M = 2 mutations, and the stem cell population size is constant or varies
stochastically around a carrying capacity. We thus turned our attention to coupled model systems in
which progenitor cells can dedifferentiate into stem cells.
Dedifferentiation With Constant Stem Cell Population Size
For the coupled system, we first considered stem cell homeostasis caused by strict asymmetric division
in the stem cell population, so the stem cell population size remains fixed. To model dedifferentiation in
this case, we built off the Moran model and assumed that when a stem cell dies and another enters the
population, the new entrant comes from the two-mutation progenitor population with probability equal
to ε times the proportion of two-mutation cells in the progenitor population. Otherwise the new stem
cell comes from replication of another stem cell. Roughly speaking, in this model the death of a stem
cell leaves a opening in the niche, which can potentially be filled by a dedifferentiated progenitor cell.
The number of progenitor cells which can successfully dedifferentiate is controlled by the number of niche
openings (stem cell deaths), not by the absolute number of progenitor cells.
Typical simulation results are shown in Fig. 4A. We found that dedifferentiation dramatically shortens
the time to fixation of two-mutation cells (Fig. 4B). For small dedifferentiation rates ε . 0.05, we also saw
good agreement between our simulations and a semi-analytical approximation for the time to fixation of
two mutation cells with selective advantage ε (Eq. (11)). This agreement suggests that under strict stem
cell homeostasis, dedifferentiation is effectively equivalent to a growth advantage for mutant stem cells.
Distributions of times to fixation of two-mutation stem cells are plotted as a function of both dedif-
ferentiation rate ε and mutation rate u in Fig. 4C. Dedifferentiation had two major effects in this model:
increasing the probability that an emergent two-mutation stem cell will fix and reducing the time between
emergence and fixation. Both of these effects act only after a two-mutation cell has been generated in
the stem cell population. (Recall that, as shown in Fig. 2, the mutation rate and selective advantage
must be unrealistically high for a nontrivial fraction of two-mutation progenitor cells to exist in the
absence of underlying two-mutation stem cells.) For all mutation rates u, the distribution of times to
fixation was roughly constant for dedifferentiation rates ε . 1/Nsc, consistent with population genetics
theory that selection is only effective when the selection coefficient is greater than the reciprocal of the
effective population size. For small mutation rates u, increasing ε beyond this threshold only marginally
shortened the total time to fixation. This is because in this case the total time to fixation is dominated
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by the time for a successful two-mutation cell to emerge, and dedifferentiation only reduces this time by
a factor of 1/
√
ρfix (Eq. 9), where ρfix is the probability of a emergent two-mutation stem cell fixing.
Under neutrality ρfix = 1/Nsc, so for our model with Nsc = 100, dedifferentiation can shorten the time
to emergence by at most a factor of 10. The dedifferentiation rate needed to significantly change this
waiting time scales linearly with Nsc (Supplemental Fig. 4C). Hence, for larger stem cell population
sizes, a small dedifferentiation rate would have a larger effect. For high mutation rates u, the effect of
dedifferentiation is more dramatic, because the time from emergence to fixation of two-mutation cells,
which dedifferentiation also shortens, is comparable to the time to emergence (Fig. 4D).
The model considered in Fig. 4 assumes that only two-mutation progenitor cells can dedifferentiate.
We also considered an alternate model in which any progenitor cell can dedifferentiate (Supplemental Ma-
terial). In this alternate model, dedifferentiation again had little effect for ε . 1/Nsc. Past that threshold
the effect was substantial, because in this model dedifferentiation speeds up the time to emergence of
two-mutation cells, because one-mutation cells fix much more quickly when they too can dedifferenti-
ate (Supplemental Fig. 4D). In addition, we considered the case in which the dedifferentiation rate is
additionally weighted by the progenitor proliferation rate, and our results did not change qualitatively
(Supplemental Material, Supplemental Fig. 4B).
Our analytical and numerical results suggest that, with intact homeostasis in the stem cell population
and normal mutation rates, dedifferentiation plays a fairly minor role in speeding up the time to cancer
initiation. We thus turned to consider the case in which homeostasis is not strict.
Dedifferentiation with Variable Stem Cell Population Size
In the previous section, we assumed that the stem cell population size was constant because homeostasis
was maintained by all divisions being strictly asymmetric. Consequently, dedifferentiated progenitor
cells could only occupy newly created openings in the stem-cell niche created by a death event in the
stem cell population. Because homeostasis is likely maintained at the population level [61], with each
stem cell division producing not strictly one stem cell but rather on average one stem cell, we next
considered a model in which the stem cell population could stochastically fluctuate around a carrying
capacity. In this model, stem cell homeostasis was maintained by dynamically altering the probabilities
of the three possible outcomes of a stem cell division: two stem cells, one stem and one progenitor cell,
or two progenitor cells (Eq. 14). Two-mutation progenitor cells each had a probability per unit time
of dedifferentiating, and dedifferentiated cells were simply added to the stem cell pool. Thus in this
model the total influx of dedifferentiated cells depended on the total number of two-mutation progenitor
cells, not on the creation of openings in the stem cell niche. (Note that in our previous model with
constant stem cell population size the rate of dedifferentiation per reproduction event was denoted ε. To
distinguish the present model, we denoted the progenitor dedifferentiation rate per cell per unit time as
δ.) Again, we asked whether dedifferentiation substantially speeds the time to carcinogenesis.
Fig. 5A and 5B show typical results from this model for a moderate dedifferentiation rate δ. After a
waiting time, the population of stems cells began to grow exponentially, because the influx of dedifferen-
tiated two-mutation progenitor cells exceeded the capacity of stem-cell division homeostasis. For larger
dedifferentiation rates, the exponential growth rate is larger (Fig. 5C and 5D), and the distribution of
progenitor ages can be distorted, with many young cells, as seen in Fig. 5E and 5F.
Exponential growth eventually occurs whenever the dedifferentiation rate exceeds a threshold δcrit.
Solving self-consistently for the influx of dedifferentiated cells and the growth rates of the stem and
progenitor cell populations, we obtained an integral equation for the growth k
k = αδ
∫
∞
0
e−kaer(a) da− 1− η
Tgen
, (17)
which provides an excellent fit to the numerical simulations (Fig. 5 and 6A,B). (For derivation details,
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see Supplemental Text.) Setting this growth rate k to zero, we found
δcrit =
1− η
αTgen
∫
∞
0
er(a) da
. (18)
Here η is probability of asymmetric stem cell division (producing one stem and one progenitor cell),
and Tgen is the mean time between stem cell divisions. (Note that if η = 1, this model reduces to
the Moran model with the population size monotonically increasing due to dedifferentiation.) Lastly,
α = 2αD,2 + αA,2 in Eq. (18) is the average number of progenitor offspring produced by a two-mutation
stem cell. Because αD,2 changes as the system attempts to maintain stem-cell homeostasis, α is actually
a stochastic variable that depends on the stem cell population size. During exponential growth α ≈ 2−η,
because the probability of symmetric divisions that give rise to two stem cells goes to zero, and all new
stem cell growth comes from dedifferentiated progenitor cells. In Eq. 18, r(a) is the growth rate of two-
mutation progenitor cells as a function of age a, so
∫
∞
0
er(a)da is the number of progenitors produced by
one two-mutation stem cell. Increasing the amplification of mutant stem cells into progenitors increases
the net dedifferentiation rate, lowering the threshold δcrit. Because the threshold δcrit depends on the age
distribution of the two-mutation cells, for a given (small) rate of dedifferentiation δ, evolving a mutant
that proliferates faster (increasing er(a)) can destabilize a system in which the number of cancerous cells
is stable and take it into exponential growth regime.
The dependence of the critical dedifferentiation rate δcrit on the growth-rate advantage s of two-
mutation progenitor cells and probability η of asymmetric cell division is shown in Fig. 6B. The critical
δ decreases rapidly as the selective advantage of two-mutation cells increases. Increasing η or Tgen also
lowers the critical dedifferentiation rate, because homeostasis is less effective when asymmetric stem cell
divisions are less frequent. Note that the exponential growth rate k does not depend on the mutation
rate (Supplemental Fig. 5A), and although the critical δ given by (18) needed for exponential growth is
a function of probability of asymmetric division η, the actual growth rate k and the time to exponential
growth is not significantly affected by changing η (see Supplemental Fig. 5B).
For dedifferentiation rates δ below δcrit, two-mutation stem cells eventually fix in the population,
but for δ > δcrit, the stem cell population is likely to begin exponential growth before fixation of two-
mutation stem cells. Thus in Fig. 6C and 6D we report the time to carcinogenesis as the time for
the two-mutation stem cell population to exceed Nsc, the nominal carrying capacity of the stem cell
compartment. In this case of stochastic stem cell homeostasis, dedifferentiation can dramatically shorten
the time to carcinogenesis, even for low mutation rates u. This is because the first two-mutation stem
cell often arises not from direct mutation of a stem cell, but rather from dedifferentiation of a progenitor
cell generated by mutations within the progenitor compartment (Fig. 6E). Although mutations in the
progenitor compartment do not affect a large fraction of progenitors, because the number of progenitor
cells is so large, the absolute number of two-mutation progenitor cells is non-negligible. Thus even small
rates of dedifferentiation can have dramatic effects. This is in contrast to the case of strict stem cell
homeostasis, in which the absolute number of two-mutation progenitor cells was unimportant, because
they needed an opening in the stem cell niche to successfully dedifferentiate.
Our results show that the case of stochastically controlled stem cell homeostasis is qualitatively dif-
ferent from the case of strict homeostasis. If homeostasis is controlled at the population level (where
decision between symmetric and asymmetric division are stochastic), dedifferentiation can overwhelm
it, leading to exponential growth of the stem cell population. Moreover, if dedifferentiated cells do not
depend on openings to colonize the stem cell niche, dedifferentiation can dramatically hasten the time to
carcinogenesis, even for low mutation rates.
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Discussion
Progression to cancer is associated with expansion of the cancer stem cell (CSC) population, but the
origin of these CSCs remains unclear. Although CSCs may arise directly from adult stem cells, they
may also arise from somewhat differentiated cells that have dedifferentiated and acquired stem cell-like
characteristics [13,14,62,63]. Stems cells replicate indefinitely, giving them a long time to accumulate the
mutations that drive carcinogenesis, but the population of actively dividing stems cells (Nsc) is small.
Progenitor cells replicate only small number of times, but the population of progenitor cells is typically
several orders of magnitude larger than the stem cell population. Thus, as a population, progenitors
undergo many more divisions, potentially letting some of these cells acquire mutations that enable them
to dedifferentiate and drive carcinogenesis. Here, using mathematical modeling, we have shown that even
a small rate of dedifferentiation may drastically shorten the time to cancer emergence.
Recent studies suggest stem cell dynamics during homeostasis are governed by neutral competition and
genetic drift [10, 24, 25]. Traditionally, stem cells were thought to always undergo asymmetric division,
always yielding a stem cell and a progenitor cell, resulting in a fixed stem cell population size. This
scenario is represented by our first model for stem cell dynamics, based on the popular Moran model.
It has been recently shown, however, that symmetric divisions also occur in adult stem cells and may
be the predominant form of division [64, 65]. Moreover, cancer stem cells have been shown to undergo
more symmetric divisions than normal stem cells [66]. Little is known, however, about how the stem
cell population size is regulated [24]. Hence, in our second model for stem cell dynamics, we made the
simplifying assumption of an a priori carrying capacity Ki. We considered a density-dependent stochastic
process, in which the degree of mean reversion is controlled through the probabilities of producing zero,
one, or two stem cell offspring. In this model, the non-constant stem cell population size S(t) tends
to return to the carrying capacity Ki, because the mean number of stem cells produced per division is
greater than one when S(t) < Ki and less than one when S(t) > Ki. (Although the stem cell population
size could, in principle, be maintained by regulating apoptosis rather than biasing division, previous
modeling suggests that regulating division is more important for hematopoietic stem cells [41].)
We compared the times to multiple mutation acquisition in our constant and variable stem cell pop-
ulation size models and found that without dedifferentiation both models yield similar results. With
dedifferentiation, however, we found that the two models differ substantially. When the stem cell popula-
tion size is constant, dedifferentiation simply acts like a selective advantage for mutant stem cells. When
the stem cell population size varies, however, dedifferentiation can additionally drive exponential growth
of the stem cell population.
If the stem cell population sizeNsc is constant, our results imply that stem cell dynamics in the coupled
stem cell-progenitor system can be approximated by a population genetics model of the stem cells alone,
as long as that model includes positive selection. In this case, we found that the dedifferentiation rate ε
must exceed 1/Nsc to substantially shorten the time to cancer acquisition, similar to classical population
genetics results that the selection coefficient must exceed the inverse population size to be effective. For
the hematopoietic system, based on the literature we assumed that the number of actively dividing stem
cells is Nsc = 100, so the dedifferentation rate must be ≈ 0.01 or higher to significantly shorten the time
to cancer.
If the stem cell population size varies and is regulated by biasing division, we found two distinct
regimes. If the dedifferentiation rate is much less than a critical value, the initial two-mutation stem
cell often arises from a normal stem cell, so the time to fixation of such a cell is similar to the case
with constant population size. If the dedifferentiation rate exceeds the critical value, however, the initial
two-mutation stem cell often arises from a dedifferentiated progenitor cell, so the time to fixation is
dramatically shorter than the case with constant population size. Moreover, in this regime the stem
cell population eventually grows exponentially, as dedifferentiating progenitor cells overwhelm stem cell
homeostasis. Note that the threshold between these two regimes is independent of the overall mutation
rate, if stem and progenitor cell mutation rates are proportional.
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The fact that mutants take a long time to reach an appreciable fraction of the stem cell population is
not typically considered in the cancer modeling literature, which often makes an implicit assumption that a
newly emerged mutant cell will not go extinct and will fix quickly. Our results show that, for high mutation
rate, the time for a mutation to fix in the population is comparable to time for a successful mutant to
first emerge, in accordance with classical results of Kimura and Ohta [51]. This is especially important
if division events are rare and the population size is large. Considering the time to some predetermined
diagnosis threshold is similar to considering the time to fixation, because the time between a selected
mutation becoming common and fixing is typically short [67]. Hence, assuming elevated mutation rate
(genetic instability) does not speed up time to carcinogenesis as much as is typically assumed, suggesting
that some form of selection (potentially through dedifferentiation) is necessary. Most tumors accumulate
hundreds of mutations, but the number of necessary “driver” mutations depends on the type of cancer.
We considered M = 2 mutations, because sequencing of acute myeloid leukemia genomes suggest that
there are two driver mutations present [49]. Moreover, recent findings on induced pluripotent stem cells
also suggestM = 2, as loss of both copies of the tumor suppressor protein p53 [68] or the activation of two
oncogenes [63] may be necessaryfor dedifferentiation. Disabling both copies of p53 improves the efficiency
of reprogramming to a stem-like state and greatly enhances the production of induced pluripotent stem
cells [69,70]. The loss of p53 also leads to the emergence of tumor cells bearing functional and molecular
similarities to stem cells [17,68]. Finally, inactivation of p53 changes the ratio of symmetric to asymmetric
division in mammary stem cells, allowing the total stem cell population to escape homeostasis [66].
(Inactivation of p53 will also lead to a higher effective mutation rate as cells with errors are permitted
to continue in the cell cycle.)
Here we focus on the hematopoietic system, in which the stem cell compartment consists of Nsc ≈ 100
active cells, and two mutations are necessary for carcinogenesis. For some other cancers, such as colon
cancer, the number of stem cells per compartment is much smaller, there are many compartments, and
the number of necessary mutations is larger. For high mutation rate, the mean time to fixation scales
linearly with Nsc (see Supplemental Fig. 4C. So in cancers with small Nsc two-mutation stem cells will
fix much faster. However, the need to accumulate more mutations will slow carcinogenesis. We expect,
however, that the qualitative effects of dedifferentiation will be similar to the hematopoietic system we
analyzed.
Our model only considers actively dividing stem cells, which in the human hematopoietic system have
been estimated to be roughly 100 [27] out of 11,000-22,000 total stem cells [54]. A more complete model
would consider both the active and quiescent stem cell populations. Transitions between these states may
be influenced by the progenitor population size, potentially acting as a negative feedback and regulating
the proliferation of cancer stem cells. In our models, cancerous cells take over the stem cell population,
but the ratio of cancer progenitor cells to cancer stem cells is fixed by the progenitor growth process.
Even when dedifferentiation drives exponential growth of the stem cells, it is their absolute number that
increases, not their proportion in the population. This is in concordance with some in vitro studies, which
suggest a fixed proportion of CSCs in a tumor [62].
Many theoretical models find that in order to accumulate multiple mutations on a reasonable time
scale, the onset of elevated mutation rate (i.e., genetic instability) should be an early event in tumorige-
nesis (reviewed in [4, 7]). The importance of genetic instability, however, depends on assumptions about
symmetric self-renewal and differentiation of stem and progenitor cells. In particular, mutations that
alter stem cell division or make committed progenitors somewhat immortal may also lead to an early
onset of cancer, diminishing the impact of genetic instability [40]. Similarly, our results show that differ-
ent assumptions about how dedifferentiation occurs (frequency-dependent reproduction versus absolute
numbers of dedifferentiating cells) dramatically alter time to carcinogenesis.
Like other mathematical models, our model suggests that eradication of cancer is dependent on
eradication of cancer stem cells [71–73]. The potential for progenitor cells to dedifferentiate and repopulate
the stem cell compartment, however, may complicate successful treatment. Our work suggests that further
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progress in understanding initiation and treatment of cancer requires a more detailed understanding
dedifferentiation and of stem cell homeostasis.
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Figure 1. Schematic representation of our model. (A) Stochastic model for stem cell division. A
stem cell can produce zero, one, or two stem cells with probabilities αD, αA, and αS , respectively.The
mean number of offering is given by m = αA +2αS . (B) Stem cells serve as an input to the proliferating
progenitor population, and the progenitor population feeds back to the stem cell pool via
dedifferentiation. (C) Mutation occurs with rate u during division and can affect cells both in the stem
cell and progenitor pools. Blue circles represent wild-type cells, red circles cells with one mutation, and
green circles cells with two mutations. (D) The sequence of models explored in this paper.
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Figure 2. Steady-state progenitor distributions in the absence of stem cell mutation. Top:
Fraction of two-mutation cells as a function of mutation rate u and proliferative advantage s for (a)
unlimited growth, (b) logistic growth for each subpopulation. Bottom: Corresponding total population
sizes. Birth/death rates of progenitor cells are given by (5) with constant death rate µ = 1 and
sigmoidal birth rate with maximal growth rate b0 = 2, bi = (1 + s)bi−1 for i = 1, 2. In (b) the carrying
capacity used is N1 = 200Nsc, N2 = 250Nsc, N3 = 300Nsc. Other parameters are as in Table 1. For
two-mutation cells to reach appreciable levels in this scenario, both the mutation rate and proliferative
advantage must be unreasonably large.
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Figure 3. Times to fixation without dedifferentiation. (A) Typical simulation trajectory for
constant stem cell population size and mutation rate u = 0.1. The numbers of zero-, one-, and
two-mutation stem cells are shown in blue, red, and green, respectively. The proportion of two-mutation
cells in the progenitor population is shown in black. (B) Times to fixation for constant and variable
stem cell population size models. Histogram of waiting times to fixation of two-mutation cells for
constant (blue) and variable stem cell population size with high fluctuations (green, ξ = 1) and low
fluctuations (red, ξ = 100). The semi-analytic distribution of waiting times calculated from Eq. (11)) is
shown in black. In both panels the mutation rate u = 0.01.
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Figure 4. Times to fixation with dedifferentiation for constant stem cell population size
(A) Typical simulation trajectory with dedifferentiation (ε = 0.02) for the same random number seed as
Fig 3A. Blue: zero-mutation stem cells, Red: one-mutation stem cells, Green: two-mutation stem cells.
Black: proportion of two-mutation cells in the progenitor population. (B) Distributions of times to
fixation of two-mutation cells under strict stem cell homeostasis. Normalized histograms (dots) and
analytical approximations (solid lines) are shown for u = 0.01 for zero dedifferentiation (red; ε = 0) and
non-zero dedifferentiation (black; ε = 0.02). (C) Median times to fixation of two-mutation cells (solid
lines) and inter-quantile ranges (shaded regions) versus dedifferentiation rate ε and mutation rate u.
(D) Mean times to emergence of a successful two-mutation stem cell (solid lines, Eq. (9)) and fixation of
such cells (dotted lines, Eq. (11)) in Moran models with selection coefficient shown. Black curve
indicates first appearance of two-mutant cell.
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Figure 5. Exponential growth given varying stem cell population size and dedifferentiation
Total number of stem cells (A, C, E) and corresponding final progenitor age distributions (B, D, F) are
shown in black. Also shown are best exponential fits of the growth rate (blue) and our semi-analytic
solution given by (17) (green). In all panels the probability of asymmetric stem cell division η = 0 and
the mean reversion parameter is ξ = 1.
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Figure 6. Fixation and exponential growth of two-mutation cells with dedifferentiation for
variable stem cell population size. A: Observed growth rate k of the stem cell population (black
curve) and the semi-analytic approximation Eq. (17) (green) for η = 0, ξ = 1, and u = 0.01. The
vertical line denotes δcrit. B: Analytically predicted critical dedifferentiation rate δcrit as a function of
asymmetric division probability η and the growth advantage s of the two-mutation progenitor
population. Exponential growth occurs for δ > δcrit. C: Normalized histogram (red crosses) of waiting
times for exponential growth of the stem cell population with stochastic homeostasis and
dedifferentiation (red) for u = 0.01, δ = 0.01. For comparison the histogram (red and black dots) as well
as the analytical distribution of times to fixation given strict homeostasis for ε = 0.01 and ε = 0 are also
shown. D: The median and inter-quantile range of times to first occurance of Nsc = 100 two-mutation
stem cells, given stochastic homeostasis and a range of dedifferentiation rates δ. For comparison, the
waiting times to fixation for Nsc = 100 given strict homeostasis (shaded areas) for the equivalent value
of ε are also shown. E: The probability that the first two-mutation stem cell arose from mutation in the
stem cell compartment, rather than dedifferentiation. Vertical line denotes δcrit. Parameters for all
simulations given in Table 1.
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Tables
Table 1. Parameter Values Used in Numerical Simulations
Parameter Meaning Value
L maximum progenitor lifespan 20 weeks [57]
Tgen/Nsc mean time between stem cell replication/death events 0.05 per week [40]
Nsc total number of active stem cells at homeostasis 100 [27]
Tgen turnover time of active stem cell population 0.05× 100 = 5 weeks
Ki active stem cell population carrying capacity Nsc [27]
bi maximal proliferation rate of progenitors with i mutations 1.5+0.2i per week
di maximal death rate of progenitors with i mutations 1.0 per week
ρb steepness of the proliferation switch 2 (assumed)
ωb age at which proliferation switches off 10 weeks
ωd age at which death switches on 0 weeks
u stem cell mutation rate per replication 10−2 [58] to 10−6 [59]
u∗ effective progenitor mutation rate (per week) u
η probability of stem cell asymmetric division 0 to 1
ε
replicating stem cell fraction from
0 to 1
dedifferentiated progenitors (constant size model)
δ
progenitor cell dedifferentiation rate
0 to 10 per week
(variable size model)
λ(t)
mean number of dedifferentiated progenitors δTgen
S(t)
∫
p2(a, t) daper stem cell reproduction event (variable size model)
Supplementary Material
Progenitor cells
Analytic solution for progenitor model
If we neglect mutation, each subpopulation of progenitor cells is governed by a single PDE (Main Text
Eq. 1), which can be solved by the method of characteristics. Without loss of generality, assume
da
dt
= 1 on
dpi
dt
= (σ(a)− µ(a))pi.
For a > t0 the solution is
pi(a, t0) = p(a0, 0)e
∫
a
a0
(σ(s)−µ(s))ds
. (19)
The behavior of this solution is determined by the initial condition pi(a0, 0). For a < t0 the solution is
pi(a, t0) = pi(0, t0)e
∫ a0
0
(σ(s)−µ(s))ds, (20)
which results in
pi(a, t) = pi(0, t− a)e
∫
a
0
(σ(s)−µ(s))ds, a < t. (21)
Because we are interested in long term behavior, we are only concerned with the solution for t > a, which
is determined by the boundary condition.
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For the stem cell boundary condition (Main Text Eq. 3), the boundary condition does not depend on
the state of the population at a previous time, and for t > a equation (21) becomes
pi(a, t) = (2αD,i + αA,i)ni(t− a)e
∫
a
0
(σ(s)−µ(s))ds. (22)
Note that the solution has the form pi(a, t) = αni(t − a)er(a), where er(a) is a steady state age distri-
bution, which multiplies the boundary condition provided by the stem cells. Hence, the shape of the
age-distribution is largely determined by the functional forms of the the birth and death of the differen-
tiated cells, which are given by Main Text Eq. 5. (Alternatively Hill functions to model age-dependent
proliferation/death rates does not qualitatively change the obtained results and uses the same number of
parameters with identical meanings.)
Using equation (22) it is possible to analytically calculate the the steady state age distribution
e
∫
a
0
(σ(s)−µ(s))ds = er(a).
For the switch-like birth and death rates given by Main Text Eq. 5 we obtain
r(a) =
(b− d)a
2
− b
2ρb
[
ln
(
cosh(ρb(a− ωb))
cosh(ρbωb)
)]
− d
2ρd
[
ln
(
cosh(ρd(a− ωd))
cosh(ρdωd)
)]
. (23)
The progenitor equation (Main Text Eq. 1) can be easily modified to have a maximal carrying capacity
Ki for each sub-population.
∂pi
∂t
+
da
dt
∂pi
∂a
= σ(a)pi(1− pi/Ki)− µ(a)pi. (24)
This does not change the qualitative nature of the solutions (See Supplemental Fig. 7B,C).
Robustness to parameter variations in the progenitor model
To test which parameters in the model have the largest effect on the steady state age distribution of
differentiated cells, we varied all the parameters in Main Text Eq. 5. For each parameter the age dependent
growth rate r(a) =
∫ a
0
(σ(s) − µ(s))ds and the steady state age distribution Nsc × er(a) are plotted in
Supplemental Fig. 8. Note that the proliferation rate b has a great effect on the age distribution of the
population. On the other hand, increasing the removal/clearance rate d does not change the maximal
value of the age distribution, only the location at which the peak begins to fall off, because it speeds up the
removal of older cells that are not proliferating. Increasing b two-fold, from 1 to 2, increases the maximal
value of the age distribution 10,000 fold (Supplemental Fig. 8B), but changing d only marginally moves
the point at which the age distribution begins to fall off, and does not affect the peak value (Supplemental
Fig. 8D). Note that this result was obtained with the assumption that ωd > ωb, i.e., most cells begin to die
off after they are done proliferating. We also tested the effect of shifting ωd and ωb. (Note that ωb or ωd=0
indicates that the rate is constant for all maturity levels.) A mutation that enables progenitor cells to
undergo more divisions before entering senescence and apoptosis has much greater effects on population
dynamics than one that enables cell removal to begin earlier. We can also conclude that enhanced cell
clearance rate, whether by the immune system or other methods will not make much difference in this
model if the proliferation rate is increased. Increasing the steepness of either switch (ρb and ρd) did
not greatly affect the maximal value of the age distribution, but made the distribution more box-shaped
(Supplemental Fig. 8F,H).
Alternative Models of Progenitor Dedifferentiation and Competition
Alternative model for progenitor cells including competition
The solutions to our progenitor model in the main text are entirely determined by the dynamics of the
stem cells, with no interactions between the different mutants. Here we considered an alternate model
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including competition between multiple progenitor cell subpopulations. Taking into account competition,
our PDE system becomes
∂pi
∂t
+
∂pi
∂a
= (1− u)σi(a)
(
1−
∑M
j=0 pi
Ki
)
ni − µi(a)pi, (25)
where the local carrying capacity of the progenitors in the absence of other subpopulations isKi
(
1− µi(1−u)σi
)
.
We can compare system (25) to the classic Lotka-Volterra model. Note that, in general, for a Lotka-
Volterra system with multiple species and non-redundant values of reaction constants, it can be shown
that there is only one stable homogeneous equilibrium with one species dominant and the other species
extinct (i.e., no co-existence steady state). However, for PDE system (25) we observe coexistence of
all three populations for different growth rates. This advection mediated coexistence for competing
populations has been previously described for spatial models of competing species [74], although in our
model advection is a maturation process with constant velocity, and no diffusive dispersal takes place.
Note that in system (25), competition is between individuals of the same maturity stage only. This
is appropriate if cells of different maturities can be considered as different cell types or occupy different
locations in the body. If the competition is between cells of all maturity stages, rather than just cells of
a given age cohort, then the competition term becomes global rather than local:
∂pi
∂t
+
∂pi
∂a
= (1− u)σi(a)
(
1−
∑M
j=1
∫
a pi(a, t) dt
Nk
)
ni − µi(a)pi(a), (26)
Adding either local or global competition does not influence the proportion ofM -mutation cells in the
progenitor model (Supplemental Fig. 9). We also looked at the effect of competition between differentiated
cells can have on time to cancer acquisition in the full deterministic-stochastic model. Considering either
local or global competition between progenitor subpopulations does not greatly affect time to mutation
acquisition in the full model (Supplemental Fig. 10B). Hence, without dedifferentiation subpopulation
competition in the progenitor model is not significant in altering the time to fixation of mutant in the
total cell population for neutral stem cell dynamics.
Alternative model of dedifferentiation for constant Nsc
In the main text, we assumed that only two-mutation progenitor cells could dedifferentiate. We also
considered the waiting time to fixation when all progenitor cells have a non-zero probability ε of dedif-
ferentiating and becoming a cancer stem cell. Every Tgen/Nsc time units, a single randomly chosen stem
cell j is removed and one cell i is born with probability given by
P (n→ n+ ei − ej) = (1− ε)
nj
Nsc
[
M∑
h=0
mh,i
nh
Nsc
]
+ ε
∫
a pi(a) da∑
i
∫
a pi(a) da
, (27)
where pi(a) is the density of differentiated cells of age a carrying i mutations, and ε is the proportion
of cells in the stem cell pool that come from dedifferentiated cells at each replication event. We also
considered a model in which all progenitor cells can dedifferentiate, but dedifferentiation is weighted by
proliferation rate σ(a) of the progenitors, with faster replicating mutants being more likely to end up
dedifferentiating.
P (n→ n+ ei − ej) = (1− ε)
nj
Nsc
[
M∑
h=0
mh,i
nh
Nsc
]
+ ε
∫
a
σi(a)pi(a) da∑
i
∫
a
σi(a)pi(a) da
. (28)
These assumptions do not significantly change the distribution of waiting times for intermediate dedif-
ferentiation rate ε (Supplemental Fig. 10B). However, the waiting time for 2 mutations in this model is
faster than model Ib for high values of ε, particularly for small u values (Supplemental Fig. 10D).
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Derivation of exponential growth rate and critical dedifferentia-
tion rate
In our variable stem cell population size model, the expected number of two-mutation stem cells produced
per stem cell reproduction event is
λ =
δTgen
S(t)
P (t). (29)
A stem cell reproduction event takes place every Tgen/S(t) time units, and the stem cell population in
changes by ∆S = λ− (1−η), where η is the probability of an asymmetric division. Taking the continuum
limit, we have
dS
dt
=
λ− (1− η)
Tgen
S. (30)
Note that if the mean number of dedifferentiated cells λ exceeds 1− η, then S(t) grows exponentially at
rate
k =
λ− (1− η)
Tgen
.
To calculate the growth rate k, recall that the two-mutation progenitor population is given by
p2(a, t) = αS(t− a)e
∫
a
0
r(x)dx = αS(t)e−kae
∫
a
0
r(x)dx (31)
where α = 2αD,2+αA,2. Here we are making the approximation that most stem cells carry two-mutations,
which is valid once exponential growth has proceeded for some time.
It follows that
P (t) =
∫
∞
0
p2(a, t) da = αS(t)
∫
∞
0
e−kaer(a) da. (32)
Substituting into Eq. 30, we then have
dS
dt
= S(t)
[
αδ
∫
∞
0
e−kaer(a) da− (1− η)
Tgen
]
. (33)
It follows that k is given by the solution to the integral equation
k = αδ
∫
∞
0
e−kaer(a) da− 1− η
Tgen
, (34)
which always has a unique solution for k.
If ∫
∞
0
er(a) da >
1− η
αδTgen
(35)
then k = λ−(1−η)Tgen > 0 and we have exponential growth of the stem cell population. This results in a
minimum dedifferentiation rate (per stem cell replication event) necessary for exponential growth given
by
δcrit =
1− η
αTgen
∫
∞
0
er(a) da
. (36)
This is equivalent to the mean number of cells coming from the dedifferentiated progenitor population
being given by
λcrit =
(1 − η)[1 + α ∫∞
0
er(a) da]
α
∫
∞
0
er(a) da
. (37)
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This threshold behavior is very similar to what one observes for the well-studied Foerster-McKendrick
Equation with an integral boundary condition:
∂pi
∂t
+
∂pi
∂a
= −µ(a)pi, (38)
p(t, 0) =
∫
∞
0
b(a) p(t, a) da. (39)
There, the behavior of the solution depends on a critical quantity
s =
∫
∞
0
b(a) exp
(
−
∫ a
0
µ(s) ds
)
da.
The solution undergoes exponential growth if s > 1, and exponential decay if s < 1 [75]. Our model,
however, has a mixed boundary condition for p2(t, a). Hence, when δ < δcrit and k < 0, the stochastic
term in the boundary condition dominates, and we get similar behaviour as the variable S(t) case with no
dedifferentiation. That is, there is neither exponential growth nor decay, and the waiting time distribution
to fixation is equivalent to the fixed N case with δ = 0.
Supplemental Figures
31
0 5 10 15 20
−5
−4
−3
−2
−1
0
1
2
3
4
5
age (weeks)
bi
rth
/d
e
a
th
 
ra
te
 
 
σ (a)
μ (a)
r (a)= ∫0a (σ (s)−μ(s)) ds
0 50 100 150 200
0
2
4
6
8
10
12 x 10
4
time
to
ta
l
 
 
Normal Differeniated Cells
1−Mutation
2−Mutation
Total
0 10 20 30 40 50
0
2
4
6
8
10
12
14
16
18 x 10
4
time
To
ta
l P
ro
ge
n
ito
rs
0 5 10 15 20
0
0.5
1
1.5
2
2.5
age
 
 
normal proliferation rate
mutant 1 proliferation rate
mutant 2 proliferation rate
death rate
0 5 10 15 20
0
0.5
1
1.5
2
2.5 x 10
4
age (weeks)
a
ge
 
di
st
rib
u
tio
n
A B C
0 5 10 15 20
0
5000
10000
15000
age (weeks)
a
ge
 
di
st
rib
u
tio
n
 
 
Wild−type
1−Mutation
2−Mutation
D E F
Figure 7. Progenitor cell dynamics for a constant stem cell population. Fixed number of
zero-mutation stem cells Nsc = 100. (A) Proliferation and death rates σ(a) (red curve) and µ(a) (blue
curve) used in the simulation and the resulting age-dependent growth rate r(a) (black curve). (B) The
total number of progenitor cells given by (Main Text Eq. 1) (solid line) and equation (24) (dotted line)
as a function of time. (C) The steady state age distribution with no competition between progenitor
cells is given by (Main Text Eq. 1) (solid line) and with logistic growth by equation (24) (dotted line).
(D-F) Progenitor dynamics for for K = 3 subpopulations with mutation rate u = 0.001. (D)
Age-dependent birth rates σ(a) given by Main Text Eq. 5. The death rate is constant. (E) The total
number of progenitor cells as a function of time for zero-mutation (blue), one-mutation (red), and
two-mutation (green) subpopulations. (F) The steady state age distribution for zero-mutation (blue),
one-mutation (red), and two-mutation (green) progenitor cells.
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Figure 8. Robustness to parameter variations in proliferation/death rates in progenitor
model. The effect of parameters in age-dependent birth and death rates, σ(a) and µ(a) (given by Main
Text Eq. 5) on the age-dependent growth rate r(a) =
∫ a
0 (σ(s) − µ(s)) ds and the steady state age
distribution er(a) in our models. (A,B) Effect of varying maximal growth rate b between 0 and 2.
(C,D). Effect of varying maximal death rate d between 0 and 5. (E,F) Effect of varying the location
(age of onset) of the proliferation switch ωb between 0 and 5. (g,h) Effect of varying the age at which
the apoptosis switch ωd is turned on between 5 and 10. (I,J) Effect of varying the steepness of the
proliferation switch ρb between 0 and 5. (K,L) Effect of varying the steepness of the apoptosis switch ρd
between 0 and 5.
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Figure 9. Steady-state progenitor distributions in the absence of stem cell mutation but
with progenitor competition. Top: The fraction of mutant cells as a function of mutation rate u
and proliferative advantage s for (A,C) local (age-dependent) competition between subpopulations
given by equation (25), and (B,D) global competition between subpopulations given by equation (26).
Bottom: Corresponding plots of total cell density. Basal dynamics are constant death rate µ = 1 and
sigmoidal birth rate with maximal growth rate b0 = 2, bi = (1 + s)bi−1 for i = 1, 2. The same carrying
capacity is used for all simulations: N1 = 200Nsc, N2 = 250Nsc, N3 = 300Nsc. Note that there is a
sharp transition zone at which mutant cells go from nearly zero fraction of total population to majority
of the differentiating cell population. However, the mutation rate u and proliferative advantage s at
which this is observed is unreasonably high, just as for the model without progenitor competition (Main
Text, Fig 2).
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Figure 10. Comparison of two Model I variants with all-mutant progenitor
dedifferentiation and two-mutant progenitor dedifferentiation. (A) Fixation time distributions
in constant stem cell population size model for potential dedifferentiation of only two-mutation
progenitors (red, Main Text Eq. 8) and potential dedifferentiation of all progenitor cells (blue, Eq. 27).
(B) Fixation time distributions in constant stem cell population size model with dedifferentiation of all
progenitor cells. Blue: all progenitor cells equally likely to dedifferentiate with dedifferentiation
probabilities given by (27)). Red: all progenitor cells can dedifferentiate with dedifferentiation
probability weighed by birth rate given by (28). Progenitor dynamics without competition (Main Text
Eq. 2). Green: all progenitor cells can dedifferentiate with dedifferentiation probability weighed by
birth rate given by (28). Progenitor dynamics with local competition given by (25). Dedifferentiation
rate used is ε = 0.02, mutation rate is u = 0.01. (C) Mean ± standard deviation of time to fixation as
the stem cell pool size Nsc is varied for two different values of the dedifferentiation rate ε. Mutation
rate is u = 0.01. (D) Median and inter-quantile range of time to fixation in alternative Model Ib as a
function of dedifferentiation rate ǫ are shown as a box-whiskers plot. All mutant cells are allowed to
dedifferentiate with probability of dedifferentiation give by eq. (27) u = 0.01 (blue), u = 0.001
(green),u = 0.0001 (red), and u = 10−5 (teal). For comparison, the waiting times to fixation in Model
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Figure 11. Supplemental Fig. 5. Characterization of exponential growth of two-mutant
population in Model II. (A) The exponential growth rate k = λ−(1−η)Tgen of the stem cell population
does not depend on the mutation rate (u = 0.01, 0.001, · · · , 10−5 for η = 0, ξ = 1). (B) The time to
exponential growth for different rates of asymmetric division (red η = 0; blue:η = 0.95) is roughly
similar. Rate of dedifferentiation is δ = 0.01. n = 1000 points are used for each distribution.
